Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
April 9, 2014
Commentary: Granulation for large postauricular defects
John Boyer
Trends in Plant Science
|
September 1, 2009
Conceptual framework for drought phenotyping during molecular breeding
Ghasem Hosseini Salekdeh, Matthew Reynolds, John Bennett, et al.
Journal of the National Cancer Institute
|
April 5, 2017
RE: Final Overall Survival: Fulvestrant 500 mg vs 250 mg in the Randomized CONFIRM Trial
Miguel Martin, John Boyer, Mary Stuart, et al.
Anticancer Research
|
May 22, 2004
5-Fluorouracil: identification of novel downstream mediators of tumour response
John Boyer, Pamela J Maxwell, Daniel B Longley, et al.
Military Medicine
|
August 25, 2010
Historical evolution of medical quality assurance in the Department of Defense
Elder Granger, John Boyer, Richard Weiss, et al.
Journal of Veterinary Medical Education
|
April 5, 2002
Group learning improves case analysis in veterinary medicine
John A Pickrell, John Boyer, Frederick W Oehme, et al.
Seminars in Oncology
|
June 13, 2003
The interaction of thymidylate synthase expression with p53-regulated signaling pathways in tumor cells
Daniel B Longley, Tariq Latif, John Boyer, et al.
Molecular Cancer Therapeutics
|
September 3, 2009
Prostate-derived factor--a novel inhibitor of drug-induced cell death in colon cancer cells
Irina Proutski, Leanne Stevenson, Wendy L Allen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 27, 2004
The roles of thymidylate synthase and p53 in regulating Fas-mediated apoptosis in response to antimetabolites
Daniel Broderick Longley, Wendy Louise Allen, Ultan McDermott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 26, 2004
Characterization of p53 wild-type and null isogenic colorectal cancer cell lines resistant to 5-fluorouracil, oxaliplatin, and irinotecan
John Boyer, Estelle G McLean, Somaiah Aroori, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
April 9, 2014
Commentary: Granulation for large postauricular defects
John Boyer
Trends in Plant Science
|
September 1, 2009
Conceptual framework for drought phenotyping during molecular breeding
Ghasem Hosseini Salekdeh, Matthew Reynolds, John Bennett, et al.
Journal of the National Cancer Institute
|
April 5, 2017
RE: Final Overall Survival: Fulvestrant 500 mg vs 250 mg in the Randomized CONFIRM Trial
Miguel Martin, John Boyer, Mary Stuart, et al.
Anticancer Research
|
May 22, 2004
5-Fluorouracil: identification of novel downstream mediators of tumour response
John Boyer, Pamela J Maxwell, Daniel B Longley, et al.
Military Medicine
|
August 25, 2010
Historical evolution of medical quality assurance in the Department of Defense
Elder Granger, John Boyer, Richard Weiss, et al.
Journal of Veterinary Medical Education
|
April 5, 2002
Group learning improves case analysis in veterinary medicine
John A Pickrell, John Boyer, Frederick W Oehme, et al.
Seminars in Oncology
|
June 13, 2003
The interaction of thymidylate synthase expression with p53-regulated signaling pathways in tumor cells
Daniel B Longley, Tariq Latif, John Boyer, et al.
Molecular Cancer Therapeutics
|
September 3, 2009
Prostate-derived factor--a novel inhibitor of drug-induced cell death in colon cancer cells
Irina Proutski, Leanne Stevenson, Wendy L Allen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 27, 2004
The roles of thymidylate synthase and p53 in regulating Fas-mediated apoptosis in response to antimetabolites
Daniel Broderick Longley, Wendy Louise Allen, Ultan McDermott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 26, 2004
Characterization of p53 wild-type and null isogenic colorectal cancer cell lines resistant to 5-fluorouracil, oxaliplatin, and irinotecan
John Boyer, Estelle G McLean, Somaiah Aroori, et al.
Page
of 2